Do neurooncological patients and their significant others agree on quality of life ratings? - Wikidata - awgldk - TriplyDB

Do neurooncological patients and their significant others agree on quality of life ratings?

Do neurooncological patients and their significant others agree on quality of life ratings?

http://www.wikidata.org/entity/Q37405864

about

Systematic review of caregiver responses for patient health-related quality of life in adult cancer care Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.The end-of-life phase of high-grade glioma patients: dying with dignity?Reliability of health-related quality-of-life assessments made by older adults and significant others for health states of increasing cognitive impairment.Using QALYs in cancer: a review of the methodological limitations.Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review.Factors influencing quality of life in adult patients with primary brain tumors.Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.Differences between Proxy and Patient Assessments of Cancer Care Experiences and Quality Ratings.Sleep disturbance of adults with a brain tumor and their family caregivers: a systematic review.Predicting distress among people who care for patients living longer with high-grade malignant glioma.Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire.Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.New Considerations in the Design of Clinical Trials for Bone Metastases.End of life care in high-grade glioma patients in three European countries: a comparative study.Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports.The ability of informal primary caregivers to accurately report cancer patients' difficulties.Primary brain tumor patients' supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilization.

P2860

Q30399917-25395D1C-FCBE-4DBA-810D-183FFF2994AB Q30840511-E4409E52-D02D-48BD-8ED4-60056659A4BC Q34176240-DFCDB3A1-D69B-41C9-AE59-DEE135B69EA5 Q35210747-4E0BAA21-28AE-4FF7-B72E-AC8B238B9003 Q36630465-BD18FED7-D216-40F9-93AA-ED530FF54B06 Q37572125-EFB4CD6A-9213-41EC-AF4E-FF9B788C1D79 Q37877688-4EDFA8B0-8596-459B-A391-A5538BA2742B Q37940559-FE441CBA-3235-47A5-9180-8CC086D6E16F Q37958051-D70E22CB-5411-40E3-BCCD-D58071A54DD1 Q37958052-08F02777-166A-4748-AC3A-A9F7C1E4A88B Q38055319-E19C724F-0500-414D-90DF-EAA7A00B64C1 Q38068465-A5BD0CB9-4440-466D-B82A-2A33F1376D84 Q38105945-8BD7EFD4-4990-4F78-AEDB-B5EE57D82E3C Q38931658-419896CA-C0CE-4AC2-860F-9B7A7ED1630C Q39199033-9726ECE9-4B20-4911-AC7D-F50C88A16B46 Q41016728-A1DB3D61-8B6B-4BCC-8CDB-580B771D768D Q41464679-EFB1BFDA-AA3D-4098-801B-A95E5F123387 Q44242592-84415B80-8608-4517-BCB0-D49DC1D22488 Q45878433-E9F6F8EB-CD91-4C02-A937-55BFA9DDDEBC Q46849306-06102C89-3897-4245-A2DD-0E79A1E6450E Q47139295-BBD173DD-D58D-4023-B39B-6095CFA2D07A Q48070490-645D8DEA-433F-48FA-9475-11476E029452 Q48151120-A2C6F059-5DEE-41A6-ABC3-28A8B55DFAF8 Q48425616-4A4F0EC8-CBC1-4BF2-A89F-66576F3C557E Q52145255-1195D2FD-D776-4965-A0B3-1D9889DC700A

P2860

Do neurooncological patients and their significant others agree on quality of life ratings?

http://www.wikidata.org/entity/Q37405864

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Do neurooncological patients a ...... ee on quality of life ratings?

@en

Do neurooncological patients a ...... ee on quality of life ratings?

@nl

type

label

Do neurooncological patients a ...... ee on quality of life ratings?

@en

Do neurooncological patients a ...... ee on quality of life ratings?

@nl

prefLabel

Do neurooncological patients a ...... ee on quality of life ratings?

@en

Do neurooncological patients a ...... ee on quality of life ratings?

@nl

P1433

Q37405864-768794FA-31BC-452B-947F-E011E7541BC9

P1476

Q37405864-4868B82A-E91F-4CE9-BB4F-AE5F516321C7

P2093

Q37405864-0A3A5F31-F333-4110-B23D-D9D7456CC772

Q37405864-170F3439-311F-4F87-BDFF-0FFD679FC813

Q37405864-8C05F6DB-36FC-4FA5-B2F7-E52313ECCC23

Q37405864-944F1319-161C-429B-B90B-0F7AF14E39B7

Q37405864-97313508-50EC-466A-B73D-E181CB27B78D

Q37405864-A635C63B-4061-4A5F-BF65-9BF99A511EE5

Q37405864-D8A2182F-2570-41C3-BB82-CB24B06799BE

Q37405864-E53D1F6E-1056-4C4D-9E37-27397F9E9092

Q37405864-E9E4125B-8002-4BB4-A2F8-F889C02E3F3E

P2860

Q37405864-073EBD05-2B5F-4019-8A49-4423048CB648

Q37405864-094C5B7E-9F23-4C3C-921B-7BC70B9F6F20

Q37405864-1FD7D75D-4332-4706-B862-E0535F8F27BD

Q37405864-22C3839E-12C8-43D9-BC90-A199BD7D00BA

Q37405864-358C975F-0A31-44F2-A50C-6F0AF99FF750

Q37405864-35B27FF0-13BD-4463-838F-0057AB3D006D

Q37405864-433EC3F1-1D5D-48A2-A20C-881578DD8158

Q37405864-4989572B-9FDF-47FD-93EB-86D650AE2CC2

Q37405864-54CC028C-8804-4124-8367-FBE272F8A8F8

Q37405864-5CF9B06E-F7E0-4F0B-BD50-FCDAE90F17CE

P2888

Q37405864-D8C7D502-11C0-483E-8757-DCE6069642D1

P304

Q37405864-601F730F-593F-4A67-B60F-A128E92EED56

P31

Q37405864-C7B39776-5052-4504-99F3-C32C10EA6361

P356

Q37405864-969CF26B-E276-4958-979A-82EF79EDFA2F

P478

Q37405864-D97AB782-5DA8-440F-8500-D59540154FF4

P50

Q37405864-B741C1C5-B9E7-4B04-A417-EE47A3A94115

P577

Q37405864-AC6A9E64-26D8-4E32-BE29-D22F3260D54C

P5875

Q37405864-4C0F835D-F19D-4DA1-8D19-08A2FAE4489C

P6179

Q37405864-6F0D8E46-C015-4C4C-9ABB-C36D6135CF35

P698

Q37405864-2E2F9E6B-1DAA-4CDE-A5E7-120353CAE7BC

P921

Q37405864-C739F60D-4215-4C82-9328-8A959D1BFD28

P932

Q37405864-AEA148A4-21F6-425E-951E-716FF087AC9A

P356

P1433

Health and Quality of Life Outcomes

P1476

Do neurooncological patients a ...... ee on quality of life ratings?

@en

P2093

Armin Muigg

http://www.w3.org/2001/XMLSchema#string

Astrid Erharter

http://www.w3.org/2001/XMLSchema#string

Bernhard Holzner

http://www.w3.org/2001/XMLSchema#string

Gabriele Schauer-Maurer

http://www.w3.org/2001/XMLSchema#string

Georg Kemmler

http://www.w3.org/2001/XMLSchema#string

Gerhard Rumpold

http://www.w3.org/2001/XMLSchema#string

Guenter Stockhammer

http://www.w3.org/2001/XMLSchema#string

Markus Hutterer

http://www.w3.org/2001/XMLSchema#string

Miriam Golser

http://www.w3.org/2001/XMLSchema#string

P2860

Temozolomide for High Grade Glioma

Statistical methods for assessing agreement between two methods of clinical measurement

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales.

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life.

Proxy perspectives regarding end-of-life care for persons with cancer.

Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment.

The use of significant others as proxy raters of the quality of life of patients with brain cancer.

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

P2888

P304

87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7525-7-87

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Giesinger

P577

2009-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26880835

http://www.w3.org/2001/XMLSchema#string

P6179

1029628577

http://www.w3.org/2001/XMLSchema#string

P698

19814834

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

2770559

http://www.w3.org/2001/XMLSchema#string